Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Ann Surg. 2020 Nov 18;276(6):e944–e954. doi: 10.1097/SLA.0000000000004644

Figure 1. Priming of the PMN oxidase by selected Metabolites.

Figure 1.

Treatment with succinate [10-1,000 μM] as compared to buffer (vehicle)-treated PMNs, primed the fMLF-activated respiratory burst in a concentration-dependent manner. Succinate concentrations <50 μM did not prime the respiratory burst vs. buffer controls (*=p<0.05 n=6).